Jeroen K. Deegens - Concepedia

Author

Jeroen K. Deegens

Also Known As

J Deegens, J K Deegens, J K J Deegens, J. Deegens, J. K. J. Deegens, J. K.J. Deegens, J.K. Deegens, J.K.J. Deegens, Jeroen Deegens, Jeroen K Deegens

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center University of Louisville University of Amsterdam Radboud Institute for Molecular Life Sciences

About

Jeroen K. Deegens is an author at Radboud University Nijmegen specializing in nephrology, medicine, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	842
2	Immunology	2	2	113
3	Medical Laboratory Science	2	2	100
4	Biochemistry	1	1	42
5	Cell Biology	1	1	42

Jeroen K. Deegens

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome Ilse M. Rood, Jeroen K. Deegens, Michael L. Merchant, Kidney International Urological ResearchUrologyRenal FunctionMedicineBioanalysis	2010	252
Microfiltration isolation of human urinary exosomes for characterization by MS Michael L. Merchant, David W. Powell, Daniel W. Wilkey, PROTEOMICS - CLINICAL APPLICATIONS	2010	201
Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis Jeroen K. Deegens, Henry Dijkman, George F. Borm, Kidney International Glomerular DiseaseGlomerulonephritisUrologyRenal FunctionFocal Segmental Glomerulosclerosis	2008	177
The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis Björn Meijers, Rutger Maas, Ben Sprangers, Kidney International Glomerular DiseaseGlomerulonephritisUrologySoluble Urokinase ReceptorFocal Segmental Glomerulosclerosis	2014	119
Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population epidemiology and outcome Jeroen K. Deegens, E. J. Steenbergen, George F. Borm, Nephrology Dialysis Transplantation	2007	97
CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis Jennifer Eymael, Shagun Sharma, Markus A. Loeven, Kidney International Glomerular DiseaseGlomerulonephritisRenal FunctionAutoimmune DiseaseVasculitis	2017	71
Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients Martien J F M Janssen, Jeroen K. Deegens, Theodoor H. Kapinga, Kidney International ThrombosisHemodialysisKidney FailureChronic Kidney DiseaseHematology	1996	58
A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation Rutger Maas, Jeroen K. Deegens, Jan A.J.G. van den Brand, BMC Nephrology	2013	56
The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series Rutger Maas, Jeroen K. Deegens, J.R. Beukhof, American Journal of Kidney Diseases Clinical CourseGlomerulonephritisUrologyMedicineRenal Pathology	2017	56
Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy Julia M. Hofstra, Jeroen K. Deegens, Hans L. Willems, Nephrology Dialysis Transplantation	2008	55

Page 1